Lacaba, Baby Girl N.
HRN: 20-78-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2022
CEFTAZIDIME 1GM (VIAL)
08/06/2022
08/12/2022
IV
72
Q8H
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes